Navigation Links
Keystone Symposia launches 2013-14 meeting series with first conference in Rio de Janeiro
Date:11/1/2013

Keystone Symposia is today convening the first conference of its 2013-2014 meeting season and its first in Rio de Janeiro, Brazil on "Advancing Vaccines in the Genomics Era" at the Windsor Barra Hotel immediately following the conclusion of the Grand Challenges in Global Health meeting for that program's grantees. The four-day conference is part of the Keystone Symposia Global Health Series, supported by the Bill & Melinda Gates Foundation, which has funded travel awards for 27 investigators from developing countries to attend. It is also sponsored by FAPERJ the Rio de Janeiro State Agency for Research Development.

Scientific organizers of the meeting are Bali Pulendran of Emory University, Chris Wilson of Bill & Melinda Gates Foundation and Rino Rappuoli of Novartis Vaccines & Diagnostics.The focus is on the design and development of vaccines leveraging advances in systems and structural biology.

One of the key presentations at the meeting will be by Peter Kwong of the National Institute of Allergy and Infectious Diseases (NIAID) of the US National Institutes of Health on Sunday morning, November 3. His paper, published in Science on November 1, demonstrates the efficacy of a new fusion glycoprotein vaccine for RSV (Respiratory Syncytial Virus), which was developed at NIAID using structure-based design. RSV is the leading cause of hospitalization for children under five years of age, plus responsible for 6.75% of deaths in children one month to one year of age and in the elderly at levels comparable to influenza virus. The vaccine is the first time the "Antibody-to-Vaccine" paradigm driving the HIV and universal flu efforts has been shown to work. More details are available in NIAID's press release at http://www.niaid.nih.gov/news/newsreleases/2013/Pages/RSV-vax.aspx.

"The publication of the work on RSV as our meeting convenes in Rio is an additional demonstration of how new, revolutionary technologies are making it possible to develop novel vaccines, and how timely and important is this Keystone Symposia meeting," commented Rino Rappuoli.


'/>"/>

Contact: Yvonne Psaila
yvonnep@keystonesymposia.org
970-262-2676
Keystone Symposia on Molecular & Cellular Biology
Source:Eurekalert

Related biology news :

1. Keystone Symposia announces grant from Alfred P. Sloan Foundation
2. Natural keystone molecules punch over their weight in ecosystems
3. Entomology 2012 to present 105 insect symposia in November
4. BiOptix to highlight new 404pi instrument at European symposia
5. LABS, Inc. Launches Suite of Next-Generation Test Offerings; Focuses on Expanding Complex Biologic Testing Portfolio in 2012
6. Elsevier launches new journal Algal Research
7. Clinical trial launches to see whether vitamin D helps treat multiple sclerosis
8. Thomson Reuters Launches Life Sciences Partner Ecosystem to Drive Collaborative R&D Drug Processes
9. WanderID Launches Breakthrough ID Product for Children, Seniors
10. Wiley-Blackwell launches new open-access journal: Food Science & Nutrition
11. MindSpec launches online Autism Reading Room
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2016)... LONDON , June 3, 2016 /PRNewswire/ ... Transport Management) von Nepal ... ,Angebot und Lieferung hochsicherer geprägter Kennzeichen, einschließlich ... weltweit führend in der Produktion und Implementierung ... an der Ausschreibung im Januar teilgenommen, aber ...
(Date:6/2/2016)... June 2, 2016   The Weather Company , an ... Ads, an industry-first capability in which consumers will be able ... to ask questions via voice or text and receive relevant ... Marketers have long sought an advertising solution ... can be personal, relevant and valuable; and can scale across ...
(Date:6/1/2016)... 1, 2016 Favorable Government Initiatives ... and Criminal Identification to Boost Global Biometrics System Market ... TechSci Research report, " Global Biometrics Market By ... and Opportunities, 2011 - 2021", the global biometrics market ... on account of growing security concerns across various end ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... June 23, 2016 Apellis Pharmaceuticals, Inc. ... clinical trials of its complement C3 inhibitor, APL-2. ... multiple ascending dose studies designed to assess the ... subcutaneous injection in healthy adult volunteers. ... as a single dose (ranging from 45 to ...
(Date:6/23/2016)... YORK , June 23, 2016 ... trading session at 4,833.32, down 0.22%; the Dow Jones Industrial ... S&P 500 closed at 2,085.45, down 0.17%. Stock-Callers.com has initiated ... INFI ), Nektar Therapeutics (NASDAQ: NKTR ), ... Therapeutics Inc. (NASDAQ: BIND ). Learn more about ...
(Date:6/23/2016)... ... June 23, 2016 , ... Velocity Products, a division ... tuned and optimized exclusively for Okuma CNC machining centers at The International Manufacturing ... collaboration among several companies with expertise in toolholding, cutting tools, machining dynamics and ...
(Date:6/22/2016)... 2016 Cell Applications, Inc. and StemoniX ... produce up to one billion human induced pluripotent ... week. These high-quality, consistent stem cells enable researchers ... spend more time doing meaningful, relevant research. This ... manufacturing process that produces affordable, reliable HiPSC for ...
Breaking Biology Technology: